| Product Code: ETC7613979 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Non-steroidal Anti-inflammatory Drugs Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Iraq Non-steroidal Anti-inflammatory Drugs Market - Industry Life Cycle |
3.4 Iraq Non-steroidal Anti-inflammatory Drugs Market - Porter's Five Forces |
3.5 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Iraq Non-steroidal Anti-inflammatory Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic conditions such as arthritis and musculoskeletal disorders in Iraq. |
4.2.2 Growing geriatric population in Iraq, who are more prone to inflammatory conditions. |
4.2.3 Rising awareness among the population about the benefits of using non-steroidal anti-inflammatory drugs for pain relief. |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for introducing new non-steroidal anti-inflammatory drugs in the Iraqi market. |
4.3.2 Presence of counterfeit or substandard drugs affecting consumer trust and market growth. |
5 Iraq Non-steroidal Anti-inflammatory Drugs Market Trends |
6 Iraq Non-steroidal Anti-inflammatory Drugs Market, By Types |
6.1 Iraq Non-steroidal Anti-inflammatory Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.1.4 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.1.5 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Topical, 2021- 2031F |
6.2 Iraq Non-steroidal Anti-inflammatory Drugs Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Arthritis, 2021- 2031F |
6.2.3 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Migraine, 2021- 2031F |
6.2.4 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Ophthalmic Diseases, 2021- 2031F |
6.2.5 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Iraq Non-steroidal Anti-inflammatory Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Iraq Non-steroidal Anti-inflammatory Drugs Market Import-Export Trade Statistics |
7.1 Iraq Non-steroidal Anti-inflammatory Drugs Market Export to Major Countries |
7.2 Iraq Non-steroidal Anti-inflammatory Drugs Market Imports from Major Countries |
8 Iraq Non-steroidal Anti-inflammatory Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for non-steroidal anti-inflammatory drugs by healthcare providers in Iraq. |
8.2 Patient adherence rate to prescribed non-steroidal anti-inflammatory drug regimens. |
8.3 Number of reported adverse reactions or side effects related to non-steroidal anti-inflammatory drug usage in Iraq. |
8.4 Rate of adoption of newer, more effective non-steroidal anti-inflammatory drugs in the Iraqi market. |
8.5 Average wait time for patients to access non-steroidal anti-inflammatory drugs in pharmacies or healthcare facilities. |
9 Iraq Non-steroidal Anti-inflammatory Drugs Market - Opportunity Assessment |
9.1 Iraq Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Iraq Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Iraq Non-steroidal Anti-inflammatory Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Iraq Non-steroidal Anti-inflammatory Drugs Market - Competitive Landscape |
10.1 Iraq Non-steroidal Anti-inflammatory Drugs Market Revenue Share, By Companies, 2024 |
10.2 Iraq Non-steroidal Anti-inflammatory Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here